Clorox (NYSE:CLX) Given New $162.00 Price Target at DA Davidson

Clorox (NYSE:CLX) had its price objective upped by DA Davidson from $152.00 to $162.00 in a research note issued to investors on Friday, Benzinga reports. DA Davidson currently has a buy rating on the stock.

A number of other brokerages have also issued reports on CLX. Jefferies Financial Group started coverage on shares of Clorox in a research report on Monday, November 13th. They set an underperform rating and a $117.00 target price on the stock. Atlantic Securities raised shares of Clorox from an underweight rating to a neutral rating in a research note on Thursday, August 3rd. Barclays lowered their price objective on shares of Clorox from $127.00 to $116.00 in a research report on Thursday, October 5th. HSBC began coverage on shares of Clorox in a research report on Friday, September 22nd. They issued a hold rating and a $146.00 target price for the company. Finally, StockNews.com started coverage on shares of Clorox in a research report on Thursday, October 5th. They issued a hold rating for the company. Six analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of Hold and an average price target of $138.13.

Clorox Stock Performance

NYSE CLX opened at $137.03 on Friday. The company has a debt-to-equity ratio of 18.92, a current ratio of 0.86 and a quick ratio of 0.54. The firm has a market capitalization of $17.00 billion, a price-to-earnings ratio of 201.51, a P/E/G ratio of 3.02 and a beta of 0.35. The company’s fifty day moving average is $129.78 and its two-hundred day moving average is $148.11. Clorox has a 52-week low of $114.68 and a 52-week high of $178.21.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.69. The business had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.31 billion. Clorox had a net margin of 1.22% and a return on equity of 195.76%. The firm’s revenue was down 20.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.93 EPS. Equities research analysts forecast that Clorox will post 4.51 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be paid a $1.20 dividend. This represents a $4.80 annualized dividend and a yield of 3.50%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is 705.88%.

Institutional Trading of Clorox

Several hedge funds and other institutional investors have recently bought and sold shares of CLX. Tyler Stone Wealth Management bought a new position in Clorox in the 2nd quarter valued at about $25,000. Bogart Wealth LLC boosted its position in Clorox by 105.6% during the 2nd quarter. Bogart Wealth LLC now owns 185 shares of the company’s stock worth $29,000 after buying an additional 95 shares during the period. American National Bank boosted its position in Clorox by 2,466.7% during the 3rd quarter. American National Bank now owns 231 shares of the company’s stock worth $30,000 after buying an additional 222 shares during the period. Ten Capital Wealth Advisors LLC lifted its position in shares of Clorox by 429.7% in the 1st quarter. Ten Capital Wealth Advisors LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 159 shares during the period. Finally, Strategic Investment Solutions Inc. IL acquired a new position in shares of Clorox in the 1st quarter worth approximately $31,000. Institutional investors and hedge funds own 77.98% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.